Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants

Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants

Abstract The aim of this study was to evaluate the death proportion and death risk of COVID-19 hospitalized patients over time and in different surges of COVID-19. This multi-center observational study was conducted from March 21, 2021 to October 3, 2021 which included the alpha and delta SARS-CoV-2...

Full description

Bibliographic Details
Main Authors:	Alireza Zali, Mahmood Khodadoost, Saeid Gholamzadeh, Shahriar Janbazi, Hassan Piri, Nazanin Taraghikhah, Khatereh Hannani, Mehdi Azizmohammad Looha, Gohar Mohammadi
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-23312-8

Similar Items

Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
by: Camino Trobajo-Sanmartín, et al.
Published: (2022-04-01)

Genetic emergence of B.1.617.2 in COVID-19
by: L. Kirola
Published: (2021-09-01)

Insights into COVID-19 Delta variant (B.1.617.2)
by: Angel Yun-Kuan Thye, et al.
Published: (2021-11-01)

Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic
by: Yuan Liu, et al.
Published: (2022-02-01)

Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
by: Daniela Loconsole, et al.
Published: (2021-11-01)

Specific Detection of SARS-CoV-2 Variants B.1.1.7 (Alpha) and B.1.617.2 (Delta) Using a One-Step Quantitative PCR Assay
by: Oran Erster, et al.
Published: (2022-04-01)

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
by: Vladimir A. Gushchin, et al.
Published: (2021-07-01)

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers
by: Steven A. Kemp, et al.
Published: (2022-06-01)

In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
by: Sabrina Jungnick, et al.
Published: (2021-09-01)

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
by: Wenlin Ren, et al.
Published: (2022-04-01)

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
by: Kerstin Kläser, et al.
Published: (2022-06-01)

Outcomes of Monoclonal Antibody Infusion Treatment During Delta (B.1.617.2) and Omicron (B.1.1.529) COVID 19 Variant Surges among Vaccinated and Unvaccinated Patients
by: Haider Ghazanfar, et al.
Published: (2022-09-01)

CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters
by: Jyotsna Dandotiya, et al.
Published: (2025-01-01)

Is the Delta Plus Variant (B.1.617.2/AY1) more serious than the Delta Variant?
by: Mohana Priya Kunasekaran, et al.
Published: (2021-12-01)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
by: Mlcochova, P, et al.
Published: (2021)

Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic
by: Abu Montakim Tareq, et al.
Published: (2021-11-01)

SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
by: Kym Lowry, et al.
Published: (2022-08-01)

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
by: Rashidul Alam Mahumud, et al.
Published: (2022-02-01)

Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants
by: Sajjad Rostamzadeh, et al.
Published: (2024-08-01)

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)
by: Ward, IL, et al.
Published: (2022)

Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics
by: Debora Ferreira Barreto Vieira, et al.
Published: (2024-01-01)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
by: Jessica Taytard, et al.
Published: (2022-06-01)

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
by: Chris Davis, et al.
Published: (2021-12-01)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
by: Yuko Sakai-Tagawa, et al.
Published: (2021-10-01)

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
by: Manish Dhawan, et al.
Published: (2022-11-01)

Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
by: Miao Lai, et al.
Published: (2023-03-01)

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
by: Haifa Khemiri, et al.
Published: (2022-09-01)

Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
by: Johannes Leiner, et al.
Published: (2022-10-01)

Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants
by: Alexander A. Bruckhaus, et al.
Published: (2023-11-01)

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
by: Paulo R.S. Sanches, et al.
Published: (2021-09-01)

COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods
by: Syed Mahfuz Al Hasan, et al.
Published: (2022-07-01)

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
by: Piotr Rzymski, et al.
Published: (2022-04-01)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
by: Stephen Y Wang, et al.
Published: (2022-01-01)

It did not stop there: rapid substitution of circulating SARS-CoV-2 variant of concern B.1.1.7 (Alpha) by variant of concern B.1.617.2 (Delta) and further evolution of different Delta sublineages in Southern Saxony-Anhalt in late summer 2021
by: Glaß Markus, et al.
Published: (2022-02-01)

Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance
by: Sandhya KS, et al.
Published: (2023-03-01)

Transmission chains of the first local outbreak cause by Delta VariantB.1.617.2 COVID-19 in Guangzhou, Southern China
by: Chun Chen, et al.
Published: (2024-01-01)

Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
by: Leonardo C. Caserta, et al.
Published: (2022-10-01)

First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain
by: Sandra Barroso-Arévalo, et al.
Published: (2022-04-01)

Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service
by: N. Radhakrishnan, et al.
Published: (2023-10-01)